Table 1. Clinicopathological characteristics of the patients.
| Baseline characteristics | Training set (n = 366) | Validating set (n = 156) | P value* |
|---|---|---|---|
| Age (year) | 48.54 (11.31) | 48.69 (11.24) | 0.891 |
| ≤60 | 315 (86.1%) | 135 (86.5%) | |
| >60 | 51 (13.9%) | 21 (13.5%) | |
| Serum prealbumin (mg/l) | 204.59 (66.85) | 197.41 (57.47) | 0.243 |
| Gender | 0.808 | ||
| Female | 315 (86.1%) | 133 (85.3%) | |
| Male | 51 (13.9%) | 23 (14.7%) | |
| Child–Pugh | 0.735 | ||
| A | 347 (94.8%) | 149 (95.5%) | |
| B | 19 (5.2%) | 7 (4.5%) | |
| BCLC | 0.169 | ||
| 0/A | 205 (56.0%) | 93 (59.6%) | |
| B | 71 (19.4%) | 36 (23.1%) | |
| C | 90 (24.6%) | 27 (17.3%) | |
| Macrovascular invasion | 0.068 | ||
| No | 276 (75.4%) | 129 (82.7%) | |
| Yes | 90 (24.6%) | 27 (17.3%) | |
| Tumor number | 0.507 | ||
| >3 | 321 (87.7%) | 140 (89.7%) | |
| ≤3 | 45 (12.3%) | 16 (10.3%) | |
| Tumor size (cm) | 0.635 | ||
| >5 | 149 (40.7%) | 67 (42.9%) | |
| ≤5 | 217 (59.3%) | 89 (57.1%) | |
| Tumor capsule | 0.175 | ||
| Complete | 171 (46.7%) | 83 (53.2%) | |
| Incomplete | 195 (53.3%) | 73 (46.8%) | |
| HBsAg | 0.462 | ||
| − | 56 (15.3%) | 20 (12.8%) | |
| + | 310 (84.7%) | 136 (87.2%) | |
| Liver cirrhosis | 0.186 | ||
| No | 105 (28.7%) | 36 (23.1%) | |
| Yes | 261 (71.3%) | 120 (76.9%) | |
| AFP (ng/ml) | 0.756 | ||
| ≤400 | 227 (62.0%) | 99 (63.5%) | |
| >400 | 139 (38.0%) | 57 (36.5%) | |
| ALB (g/l) | 0.325 | ||
| ≤35 | 41 (11.2%) | 13 (8.3%) | |
| >35 | 325 (88.8%) | 143 (91.7%) | |
| AST (U/l) | 0.140 | ||
| ≤40 | 183 (50.0%) | 67 (42.9%) | |
| >40 | 183 (50.0%) | 89 (57.1%) | |
| ALT (U/l) | 0.940 | ||
| ≤40 | 189 (51.6%) | 80 (51.3%) | |
| >40 | 177 (48.4%) | 76 (48.7%) | |
| TBIL (μmol/l) | 0.651 | ||
| ≤21 | 321 (87.7%) | 139 (89.1%) | |
| >21 | 45 (12.3%) | 17 (10.9%) |
Data are n (%) or mean (SD), unless otherwise specified.
*
Pearson's chi-squared test or Fisher's exact test. P value<0.05 indicates a significant difference between the two groups.